Literature DB >> 23777619

Determination of an unstable pentapeptide, monocyte locomotion inhibitory factor, in dog blood by LC-MS/MS: application to a pharmacokinetic study.

Huafang Jiang1, Ji Li, Xin Zhao, Yu Zhou, You Li, Fanlu Sun, Xun Hu, Jinghua Huang, Yaocheng Rui, Guorong Fan.   

Abstract

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and established for the quantitative determination of monocyte locomotion inhibitory factor, a pentapeptide (Met-Gln-Cys-Asn-Ser) produced by Entamoeba histolytica in axenic culture, in dog blood. The main challenge was the chemical and enzymatic instability of the peptide which was successfully overcome. After a simple protein precipitation, MLIF was separated from AS-5 (Met-Gln-Gly-Asn-Ser), acted as an internal standard, on a Gemini C18 column (5 μm, 50 mm × 4.6 mm i.d.) using a gradient elution of acetonitrile (0.2% formic acid) and water (0.2% formic acid) and detected by electrospray ionization tandem mass spectrometry. Excellent linearity was achieved (r>0.9943) over the linear range 5-1000 ng/ml using 0.2 ml blood sample. The validation results demonstrated that this method was specific, accurate and precise. It was successfully applied in measuring MLIF following intravenous infusion its administration at 0.2, 0.4, and 0.8 mg/kg in beagle dogs to support the pre-clinical pharmacokinetic study.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23777619     DOI: 10.1016/j.jpba.2013.05.013

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Enhanced UHPLC-MS/MS determination of a therapeutic heptapeptide mimic for inflammatory-related diseases in rat plasma: application to a pharmacokinetic study.

Authors:  Liang Li; Shumei Ma; Yan Qin; Li Liu
Journal:  RSC Adv       Date:  2019-10-15       Impact factor: 4.036

2.  Monocyte locomotion inhibitory factor produced by E. histolytica improves motor recovery and develops neuroprotection after traumatic injury to the spinal cord.

Authors:  Gabriela Bermeo; Antonio Ibarra; Elisa García; Adrian Flores-Romero; Guadalupe Rico-Rosillo; Rubén Marroquín; Humberto Mestre; Carmina Flores; Francisco Blanco-Favela; Raúl Silva-García
Journal:  Biomed Res Int       Date:  2013-11-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.